Timothy Kutzkey

Timothy W.
Kutzkey was the founder of Nurix Therapeutics, Inc., founded in 2009, where the title held was Chairman from 2016 to 2019.
Dr. Kutzkey is the founder of Kimia Therapeutics, Inc., founded in 2023, holding the title of Director starting in 2023.
Dr. Kutzkey is also the founder of Nura Bio, Inc...
Current jobs include Chief Executive Officer at Reina Bio, Inc.; Chairman at Neurona Therapeutics, Inc.; Chairman at Carmot Therapeutics, Inc. since 2010; Director at Kallyope, Inc.; Director at Plexium, Inc.; Director at Synthekine, Inc.; Director at Cajal Therapeutics; Director at InduPro, Inc.; Director at Surrozen, Inc. starting in 2025; Managing Partner at The Column Group LLC since 2007; and Managing Partner at TCG Labs-Soleil.
Former jobs include President, Chief Executive Officer & Director at Peloton Therapeutics, Inc.; Chief Executive Officer & Director at Surrozen Operating, Inc.; Director at Cyterix Pharmaceuticals, Inc.; Independent Director at Surrozen, Inc. from 2016 to 2024; and Principal at KAI Pharmaceuticals, Inc. from 2006 to 2007.
Education includes an undergraduate degree from Stanford University conferred in 1997 and a doctorate from the University of California, Berkeley conferred in 2005.